about
Dynamic pathology of islet endocrine cells in type 2 diabetes: β-Cell growth, death, regeneration and their clinical implicationsProtein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its ComplicationsHyperglycemic Stress and Carbon Stress in Diabetic GlucotoxicityStreptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicitySphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretionAssociation between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus.Protein malnutrition potentiates the amplifying pathway of insulin secretion in adult obese mice.Glucose-induced inhibition of insulin secretion.Minireview: Autophagy in pancreatic β-cells and its implication in diabetes.Pancreatic β-cell identity in diabetes.Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice.Stimulation of insulin secretion by large-dose oral arginine administration in healthy adults.Sodium glucose co-transporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline.Pathways governing development of stem cell-derived pancreatic β cells: lessons from embryogenesis.Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: Are they reliable models to study Type 2 Diabetes mellitus?Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes.Geniposide accelerates proteasome degradation of Txnip to inhibit insulin secretion in pancreatic β-cells.Differentiation of human pluripotent stem cells into two distinct NKX6.1 populations of pancreatic progenitors.
P2860
Q26752746-B8096125-34EB-4AD1-AF68-117D43C9B3E9Q26752842-CCE25AD9-FCCA-4447-BFC3-6051B5A07341Q26773988-BE85FF74-431B-4CD5-BA9A-6123FBBE0D6AQ28260875-6A37A517-8834-4DB1-BA1B-4FA7CEE2F223Q33677977-86DC30DA-FEDF-42A5-B697-7688D1C5F2D1Q37140799-C8DB59C1-B84A-44AB-85C0-60BE9A0D23E2Q37261033-57BF6DD4-E617-4D7E-B702-CD98137D2C1EQ38172596-0818BAC3-5827-429C-A635-D3444BD4A7EAQ38336639-9ED17EB9-9B89-4046-B357-A489AAE4907CQ38951177-787222BC-066F-48B0-9302-FEEDA05F6FB9Q39069908-6D1DF0EC-E4FC-49B4-AE4D-DA47C5010101Q41015734-0F113645-3859-4872-B36B-886E693694BBQ41812480-074FDCD0-BE3E-47AD-A3F7-327F4FE97625Q42696994-925C3B5F-F764-4741-A707-F1132EDE16F1Q46501784-4534C4C8-39EE-4816-819C-D1AF2EDD3B99Q47127780-2D5D661D-D015-48B3-BA85-438E4692CE33Q50475837-CD4BE985-13DF-419E-ABAF-3019E12ED3E0Q51246114-2922C4DE-A2D9-490E-8738-E3DC0FD44416Q52609387-51899ADD-22E8-4280-8A98-58626A71DD90
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
β-Cell failure in type 2 diabetes.
@ast
β-Cell failure in type 2 diabetes.
@en
β-Cell failure in type 2 diabetes.
@nl
type
label
β-Cell failure in type 2 diabetes.
@ast
β-Cell failure in type 2 diabetes.
@en
β-Cell failure in type 2 diabetes.
@nl
prefLabel
β-Cell failure in type 2 diabetes.
@ast
β-Cell failure in type 2 diabetes.
@en
β-Cell failure in type 2 diabetes.
@nl
P2093
P2860
P1476
β-Cell failure in type 2 diabetes.
@en
P2093
Erol Cerasi
Gil Leibowitz
Nurit Kaiser
P2860
P356
10.1111/J.2040-1124.2010.00094.X
P577
2011-04-01T00:00:00Z